Is a Five Marker Panel with Basal Marker Expression (EGFR and/or CK5/6) Superior to a Three Marker Panel in Predicting Prognosis in Molecular Subtypes of Breast Carcinoma? A Comparative Study

Breast cancer is heterogeneous, as indicated by the fact that tumours with identical morphologic and immunohistochemical characteristics have different clinical behaviour and treatment responses. This cleared the door for microarray-based global gene expression profiling (GEP) and new molecular subtyping techniques

Read More